Skip to main content
. 2022 Aug 26;1(3):100058. doi: 10.1016/j.jacadv.2022.100058

Table 5.

Rhythm Control Therapy at Last Follow-Up

N n (%)
Episode management 322
 Class I antiarrhythmicsa 26 (8.0)
 Class III antiarrhythmicsb 120 (37.0)
 Direct current cardioversion 122 (38.0)
Antiarrhythmic drugs at last follow-up 322
 Class I antiarrhythmicsa 7 (2.0)
 Class III antiarrhythmicsb 51 (16.0)
Percutaneous catheter ablation 322
 Atrial fibrillation 9 (3.0)
 Intra-atrial re-entrant tachycardia
 Typical atrial flutter 67 (21.0)
 Atypical right atrial flutter 45 (14.0)
 Atypical left atrial flutter 1 (0.3)
 Focal atrial tachycardia 14 (4.0)
Antiarrhythmic surgery 322
 Right atrial Maze 121 (38.0)
 Left atrial Maze 1 (0.3)
 Biatrial Maze 25 (8.0)

’N’ signifies number of patients with available data and ‘n’ signifies number of patients with positive results for each variable.

a

Quinidine, procainamide, flecainide, propafenone.

b

Sotalol, dofetilide, amiodarone.